Studies on Ketamine Assisted Therapy’s Impact on Mental Health: EntheoTech Event w Dr Zach Walsh

Ketamine is an exciting intervention with impressive results for mental health conditions, and thus offers huge potential in easing the major health challenge of our generation – the opioid crisis. Watch to learn more with EntheoTech’s Principal Investigator, Dr. Zach Walsh. EntheoTech is a Kelowna based developer of psilocybin products, natural medicines, interventional pain treatments, and psychedelic assisted therapies to optimize mental health and relieve chronic pain. In late April 2022, several members of the EntheoTech medical team gave presentations to an audience of over 70 physicians, mental health professionals, pharmacists, and laypeople on the science of ketamine and our unique approach to ketamine-assisted therapy that we offer at our EntheoMed Ketamine Suite. In this video, you’ll watch our Principal Investigator Dr Zach Walsh the stage and provide an overview of:

🔹 His recent comprehensive review paper co-written with a team of collaborators, covering all therapeutic applications of ketamine studied to date

🔹 The impressive and robust results of ketamine treatment for major depressive disorder, suicidal ideation and bipolar disorder

🔹 A small but promising body of evidence that suggests that ketamine may also be effective for anxiety disorders, post traumatic stress disorder, obsessive compulsive disorders and substance use disorders.